Background: Reductions in albuminuria of more than 30% are considered a strong marker of
delay of chronic kidney disease (CKD) progression. Single renin–angiotensin system (RAS) …

Objective Anemia is a frequent comorbidity in hemodialysis patients that can be successfully
treated by administering erythropoiesis-stimulating agents (ESAs). ESAs dosing is currently …

Background Post-myocardial infarction (MI) patients have a doubled rate of kidney function
decline compared with the general population. We investigated the extent to which high …

Cyclophosphamide (CP), a bifunctional alkylating agent used in chemotherapy has been
reported to induce organ toxicity mediated by generation of reactive oxygen species and …

Background Chronic kidney disease (CKD) patients, especially those with end stage renal
disease (ESRD) undergoing hemodialysis (HD), exhibit high prevalence of periodontitis …

Background The US Centers for Medicare & Medicaid Services assess patient experiences
of care as part of the end-stage renal disease prospective payment system and Quality …

A doença renal crônica é uma síndrome clínica decorrente da perda lenta, progressiva e
irreversível da taxa de filtração glomerular, fazendo o paciente necessitar de uma terapia de …

Background This study will assess measures of vascular health and inflammation in
Aboriginal Australian adults with chronic kidney disease (CKD), and determine if intensive …

Different approaches for preventing, reducing, halting, and reversing chronic kidney disease
(CKD) have been described in the medical literature. However, all related factors have not …

Background: The incidence and prevalence rates of end‐stage renal disease in Taiwan rank
among the highest in the world. The quality of life of these patients deserves close attention …